Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
1.98
Nov 13 • 3:58 PM ET Dollar change+0.08 Percentage change(4.21%)
Aftermarket Close
2.12
Aftermarket • 7:51 PM ET Dollar change+0.14 Percentage change(7.07%)
Index
-
Market Cap
14.48M
Enterprise Value
13.58M
Income
-8.92M
Sales
0.56M
Book/sh
3.22
Cash/sh
0.30
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
-
IPO
Sep 05, 2024
P/E
-
Forward P/E
-
PEG
-
P/S
25.86
P/B
0.61
P/C
6.52
P/FCF
-
EV/EBITDA
-
EV/Sales
24.25
Quick Ratio
17.36
Current Ratio
17.39
Debt/Eq
0.01
LT Debt/Eq
0.00
Option/Short
No / Yes
EPS (ttm)
-4.22
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
- -
Sales past 3/5Y
-8.37% -7.12%
EPS Y/Y TTM
-62.68%
Sales Y/Y TTM
82.31%
EPS Q/Q
39.89%
Sales Q/Q
49.47%
Earnings
-
EPS/Sales Surpr.
- -
Insider Own
17.46%
Insider Trans
0.00%
Inst Own
0.18%
Inst Trans
3.59%
ROA
-56.27%
ROE
-62.99%
ROIC
-37.75%
Gross Margin
33.25%
Oper. Margin
-1471.55%
Profit Margin
-1602.33%
SMA20
-20.97%
SMA50
-46.60%
SMA200
-59.09%
Trades
Shs Outstand
6.84M
Shs Float
6.04M
52W High
18.40 -89.24%
52W Low
1.63 21.47%
Volatility
23.81% 21.06%
ATR (14)
0.48
RSI (14)
34.63
Beta
3.13
Rel Volume
0.57
Avg Volume
59.26K
Volume
33,891
Perf Week
15.11%
Perf Month
-50.62%
Perf Quarter
-55.15%
Perf Half Y
-59.29%
Perf YTD
-70.59%
Perf Year
-79.85%
Perf 3Y
-
Perf 5Y
-
Perf 10Y
-
Recom
-
Target Price
-
Prev Close
1.90
Price
1.98
Change %
4.21%
Oct-28-26 08:00AM
Oct-02-26 09:00AM
Aug-26-26 02:20PM
Aug-14-26 06:15PM
Aug-11-26 09:24AM
08:30AM Loading…
Jul-15-26 08:30AM
Apr-23-26 04:05PM
Jan-13-26 08:30AM
Dec-05-25 04:05PM
Nov-18-25 03:30AM
Oct-23-25 04:15PM
Sep-04-25 01:01PM
Aug-18-25 12:00AM
Aug-01-25 09:28AM
Mar-17-25 08:31AM
04:08PM Loading…
Sep-06-24 04:08PM
Sep-05-24 09:31AM
iTonic Holdings Ltd. operates as a holding company with interests in providing healthcare solutions. The firm through its subsidiaries engages in the development and commercialization of brachytherapy TPS specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company was founded in 1998 and is headquartered in Beijing, China.
CEO & Chairman of the BoardMr. Jianfei Zhang
Chief Financial OfficerMs. Simin Tan